CONCLUSION
In instances of this nature, the individual is required to undergo a
series of procedures and investigations. The evaluation process relies
on the individual’s medical history, which, in this instance, is not
significant. The rarity of this case is attributed to the presence of
significant pulmonary hypertension characterized by a pulmonary artery
diameter measuring 38mm and the additional active hemoptysis, which
necessitated a delay in performing bronchoscopy due to the potential
risk of bleeding. Despite being a well-acknowledged therapeutic
technique for patients experiencing severe recurrent hemoptysis and
providing prompt control of bleeding, embolotherapy still carries a
notable risk of re-bleeding. In the current context, the heightened
severity of the illness may lead to exacerbated long-term complications
when surgical intervention is employed, due to the patient’s atypical
anatomical variation of the PDA in relation to the aorta as well as the
severity of the symptoms presented. Furthermore, this particular
instance serves as a cautionary tale for medical professionals to
exercise vigilant monitoring of patients presenting with identical
symptoms and displaying signs of pulmonary hypertension.